KWF offers funding options for all research phases. In addition, KWF introduces guideline amounts for project budgets rather than maximum budgets; this means there is no longer a limit on the budget that can be requested for a project. Researchers can request what they need to take a new discovery/development through to the next phase. Furthermore, KWF will have the option of providing continuation funding in the event of promising results or to end funding early if the perspectives of a project or development change.
The funding framework consists of various types of funding, which can be applied for during each research phase. The applicable funding and eligibility conditions depend on both the project’s current research phase and the type of funding applied for.
These funding types are available from June 27, 2016:
The funding type for research projects with a limited scope in terms of time and research groups.
Young Investigator Grant
The funding type for young, talented researchers.
Unique High Risk Project
This type of funding offers the possibility of performing short-term preliminary work on the basis of a good, but not entirely crystallised idea.
Funding for research projects performed by or within more complex and/or bigger collaborations.
Funding for initiatives which support oncological research and a faster translation to concrete application for patients and the public.
Funding for implementation of concrete applications, which are positively evaluated in clinical setting and show demonstrable added value compared to the current practice, into oncology policy and practice at national scale.